We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




A Novel Fluorescent Marker System Labels Replicating Cells in Vivo

By LabMedica International staff writers
Posted on 10 Dec 2012
A strain of mice was genetically engineered to express a fluorescent label in cells that were dividing, which allowed them to be isolated and analyzed.

Until now, the isolation and study of replicating cells from living animals typically involved immunostaining for intracellular markers of proliferation, causing the loss of sensitive biological material. More...
This situation has been greatly improved by investigators at the Hebrew University of Jerusalem (Israel) who genetically engineered a line of mice to express a green fluorescent CyclinB1-GFP fusion reporter that marked replicating cells in the S/G2/M phases of the cell cycle. The green color disappeared upon completion of cell division.

The investigators employed flow cytometry to isolate live replicating cells from the livers of the genetically engineered mice and compared their transcriptome to that of quiescent cells to reveal gene expression programs associated with in vivo cell proliferation.

They reported in the September 20, 2012, online edition of the journal Developmental Cell that replicating hepatocytes had reduced expression of genes characteristic of liver differentiation. Thus, in the replicating liver cells there was a significant decrease in the expression of genes responsible for key liver functions such as fatty acid and amino acid metabolism.

The investigators concluded that when differentiated cells divide, they temporarily shift to a less differentiated state. This condition is similar to that of cancer cells, which are less differentiated than normal cells and proliferate rapidly.

The fluorescent cell replication reporter system was shown to provide a powerful platform for gene expression and metabolic and functional studies of dividing cells in their in vivo niche.

Related Links:

Hebrew University of Jerusalem




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.